首页|期刊导航|中国神经再生研究（英文版）|Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer 's disease: new biomarkers for diagnosis and disease progression?

Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer 's disease: new biomarkers for diagnosis and disease progression?

Rosa Maria Corbo Rita Businaro Daniela Scarabino

中国神经再生研究（英文版）2021，Vol.16Issue(7)：1397-1398,2.

Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer 's disease: new biomarkers for diagnosis and disease progression?

Rosa Maria Corbo ¹Rita Businaro ²Daniela Scarabino³

作者信息

1. Department of Biology and Biotechnology,Sapienza University,Rome,Italy
2. Department of Medico-Surgical Sciences and Biotechnologies,Sapienza University of Rome,Latina,Italy
3. CNR Institute of Molecular Biology and Pathology Rome,Italy
折叠

摘要

引用本文复制引用

Rosa Maria Corbo,Rita Businaro,Daniela Scarabino..Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer 's disease: new biomarkers for diagnosis and disease progression?[J].中国神经再生研究（英文版）,2021,16(7):1397-1398,2.

基金项目

The present work was supported by Sapienza University of Rome(2017/2018 grants allotted to RB and RMC). （2017/2018 grants allotted to RB and RMC）

中国神经再生研究（英文版）

OACSCDCSTPCDSCI

ISSN：1673-5374

访问量0

下载量0

段落导航